Jutaek Nam
Jutaek Nam publishes mostly in Immunology, Biomedical Engineering and Molecular Biology, on topics such as Nanoplatforms for cancer theranostics, Immunotherapy and Immune Responses and Gold and Silver Nanoparticles Synthesis and Applications.
- World rank
- #137,863 of 7,710,434 ranked researchers
- Rank in South Korea
- #717 of 162,609
- Works
- 56
- Citations
- 7.1k
- Citations per work
- 127.0
What does Jutaek Nam research?
Jutaek Nam's work is mostly in Immunology and Microbiology (21%), Engineering (18%), Materials Science (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1934.0%
- Engineering1017.6%
- Materials Science916.4%
- Life Sciences1730.9%
- Everything else1526.6%
- Health Sciences58.5%
- Medicine58.5%
- 1Immunology21% of their works
- 2Biomedical Engineering18% of their works
- 3Molecular Biology10% of their works
- 4Materials Chemistry9% of their works
- 5Oncology8% of their works
- 6Electronic, Optical and Magnetic Materials7% of their works
Research topics
- Nanoplatforms for cancer theranostics
- Immunotherapy and Immune Responses
- Gold and Silver Nanoparticles Synthesis and Applications
- Nanoparticle-Based Drug Delivery
- Cancer Immunotherapy and Biomarkers
- Quantum Dots Synthesis And Properties
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
Which keywords describe Jutaek Nam's research?
The keywords of their largest research topics: Nanoparticles, Photothermal Therapy, Tumor Targeting, Fluorescence Imaging, Biomedical Applications, Photodynamic Therapy, Reactive Oxygen Species and Dendritic Cells.
- RNA Interference
- DNA nanotechnology
- Nanocrystals
- Immune Checkpoint Blockade
- Drug Delivery
- Gold Nanoparticles
- Dendritic Cells
- Photodynamic Therapy
- Fluorescence Imaging
- Photothermal Therapy
- Nanoparticles
- Tumor Targeting
- Biomedical Applications
- Reactive Oxygen Species
- Immunity
- Plasmonic Nanoparticles
- Nanocarriers
- PD-1 and PD-L1
- Quantum Dots
- Self-Assembly
- siRNA Delivery
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Nanoparticles373 topics
- Photothermal Therapy332 topics
- Tumor Targeting322 topics
- Fluorescence Imaging292 topics
- Biomedical Applications232 topics
- Photodynamic Therapy211 topic
- Reactive Oxygen Species211 topic
- Dendritic Cells181 topic
- Immunity181 topic
- Gold Nanoparticles121 topic
- Plasmonic Nanoparticles121 topic
- Drug Delivery111 topic
- Nanocarriers111 topic
- Immune Checkpoint Blockade91 topic
- PD-1 and PD-L191 topic
- Nanocrystals81 topic
- Quantum Dots81 topic
- DNA nanotechnology51 topic
- Self-Assembly51 topic
- RNA Interference41 topic
- siRNA Delivery41 topic
Where does Jutaek Nam work?
Jutaek Nam's main affiliation in the publication record is Pohang University of Science and Technology, South Korea.
How many publications and citations does Jutaek Nam have?
OpenAlex counts 56 works and 7,110 citations for Jutaek Nam, an h-index of 32, ranking #137,863 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jutaek Nam. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.